The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2023
Filed:
Apr. 20, 2017
The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);
British Columbia Cancer Agency Branch, Vancouver, CA;
Julius-maximilians—university of Würzburg, Würzburg, DE;
Oregon Health & Science University, Portland, OR (US);
Hospital Clinic DE Barcelona, Barcelona, ES;
Universitat DE Barcelona, Barcelona, ES;
Oslo University Hospital Hf, Oslo, NO;
Board of Regents of the University of Nebraska, Lincoln, NE (US);
The Cleveland Clinic Foundation, Cleveland, OH (US);
Mayo Foundation for Medical Education and Research, Rochester, MN (US);
Louis M. Staudt, Bethesda, MD (US);
David William Scott, Vancouver, CA;
George W. Wright, Rockville, MD (US);
Andreas Rosenwald, Wurzburg, DE;
Pau Abrisqueta, Barcelona, ES;
Rita Braziel, West Linn, OR (US);
Elias Campo Guerri, Barcelona, ES;
Wing C. Chan, Pasadena, CA (US);
Joseph M. Connors, Vancouver, CA;
Jan Delabie, Toronto, CA;
Diego Villa, Vancouver, CA;
Kai Fu, Omaha, NE (US);
Randy D. Gascoyne, North Vancouver, CA;
Timothy Greiner, Council Bluffs, IA (US);
Elaine S. Jaffe, Great Falls, VA (US);
Pedro Jares, Barcelona, ES;
Anja Mottok, Vancouver, CA;
German Ott, Bietigheim-Bissingen, DE;
Lisa M. Rimsza, Scottsdale, AZ (US);
Graham Slack, Richmond, CA;
Dennis Weisenburger, Glendora, CA (US);
Erlend B. Smeland, Oslo, NO;
James Robert Cook, Shaker Heights, OH (US);
The United States of America, as represented by the Secretary, Department of Health and Human Services, Bethesda, MD (US);
British Columbia Cancer Agency Branch, Vancouver, CA;
Julius-Maximilians-University of Würzburg, Würzburg, DE;
Oregon Health & Science University, Portland, OR (US);
Hospital Clinic de Barcelona, Barcelona, ES;
Universitat de Barcelona, Barcelona, ES;
Oslo University Hospital HF, Oslo, NO;
The Cleveland Clinic Foundation, Cleveland, OH (US);
Mayo Foundation for Medical Education and Research, Rochester, MN (US);
Abstract
The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.